AbstractThis article is a summary of the conference “Clinical and technological transition in breast cancer” that took place in the Congress of the Spanish Society of Radiation Oncology, placed in Vigo (Spain) on June 21, 2013. Hugo Marsiglia and Philip Poortmanns were the speakers, the first discussed about “Clinical and technological transition” and the second about “EORTC clinical trials and protocols”
Breast cancer is acknowledged as an international priority in health care. It is currently the most ...
This article reflects on progress made in recent years with respect to bench-to-bedside research in ...
The most frequent cancer type in females in the world is breast cancer; with a lifetime risk of the ...
AbstractThis article is a summary of the conference “Clinical and technological transition in breast...
The recognition that early breast cancer is a spectrum of diseases each requiring a specific systemi...
Breast cancer is distributed worldwide, and its number accounts for 23% of all cancer patients. This...
According to the most recent epidemiological studies, breast cancer shows the highest incidence and ...
Breast cancer is the most prevalent life-threatening cancer in women. Optimizing therapy to increase...
Breast cancer is fast becoming the leading cause of oncologic morbidity and mortality among women wo...
Breast cancer has become curable for the majority of women in Western Europe and North America. Adva...
Insights into tumour biology of breast cancer have led the path towards the introduction of targeted...
The 15th St. Gallen International Breast Cancer Conference 2017 in Vienna, Austria reviewed substant...
Background: The publication of results from randomized clinical trials can have a dramatic effect on...
The 15th St. Gallen International Breast Cancer Conference 2017 in Vienna, Austria reviewed substant...
Breast cancer has become curable for the majority of women in Western Europe and North America. Adva...
Breast cancer is acknowledged as an international priority in health care. It is currently the most ...
This article reflects on progress made in recent years with respect to bench-to-bedside research in ...
The most frequent cancer type in females in the world is breast cancer; with a lifetime risk of the ...
AbstractThis article is a summary of the conference “Clinical and technological transition in breast...
The recognition that early breast cancer is a spectrum of diseases each requiring a specific systemi...
Breast cancer is distributed worldwide, and its number accounts for 23% of all cancer patients. This...
According to the most recent epidemiological studies, breast cancer shows the highest incidence and ...
Breast cancer is the most prevalent life-threatening cancer in women. Optimizing therapy to increase...
Breast cancer is fast becoming the leading cause of oncologic morbidity and mortality among women wo...
Breast cancer has become curable for the majority of women in Western Europe and North America. Adva...
Insights into tumour biology of breast cancer have led the path towards the introduction of targeted...
The 15th St. Gallen International Breast Cancer Conference 2017 in Vienna, Austria reviewed substant...
Background: The publication of results from randomized clinical trials can have a dramatic effect on...
The 15th St. Gallen International Breast Cancer Conference 2017 in Vienna, Austria reviewed substant...
Breast cancer has become curable for the majority of women in Western Europe and North America. Adva...
Breast cancer is acknowledged as an international priority in health care. It is currently the most ...
This article reflects on progress made in recent years with respect to bench-to-bedside research in ...
The most frequent cancer type in females in the world is breast cancer; with a lifetime risk of the ...